Bristol Myers Squibb hasn’t had a lot luck in its efforts to develop most cancers therapies referred to as T-cell engagers. However the pharmaceutical firm is not achieved with this type of focused most cancers remedy but, and is now turning to Janux Therapeutics to see if the biotech know-how can yield a drug that may be taken to the […]